Mesoblast (MESO) Debt to Equity (2018 - 2022)

Mesoblast has disclosed Debt to Equity across 5 years of filings, most recently posting $0.19 for Q2 2022.

• Debt to Equity for Q2 2022 came in at $0.19, up 19.94% year-over-year; the trailing twelve-month figure through Jun 2022 was $0.19 (up 19.94% YoY), and the FY2022 annual result was $0.19, up 19.94% from the prior year.
• Debt to Equity came in at $0.19 for Q2 2022 at Mesoblast, up from $0.16 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.21 in Q2 2020 to a low of $0.16 in Q2 2021.
• The 5-year median for Debt to Equity is $0.17 (2019), against an average of $0.18.
• Across the five-year window, Debt to Equity increased 22.86% in 2020 and fell 21.92% in 2021, its largest moves.
• Mesoblast's Debt to Equity stood at $0.17 in 2018, then increased by 0.98% to $0.17 in 2019, then rose by 22.86% to $0.21 in 2020, then dropped by 21.92% to $0.16 in 2021, then increased by 19.94% to $0.19 in 2022.
• The last three Debt to Equity figures came in at $0.19 (Q2 2022), $0.16 (Q2 2021), and $0.21 (Q2 2020), per Business Quant data.